oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Epigenetic alterations in inflammatory bowel disease: the complex interplay between genome-wide methylation alterations, germline variation, and gene expression
Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, UK.
Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, UK.
Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, UK.
Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, UK.
Show others and affiliations
2017 (English)In: The Lancet, ISSN 0140-6736, E-ISSN 1474-547X, Vol. 389, no Suppl. 1, p. 52-52Article in journal (Refereed) Published
Place, publisher, year, edition, pages
Elsevier, 2017. Vol. 389, no Suppl. 1, p. 52-52
National Category
General Practice
Identifiers
URN: urn:nbn:se:oru:diva-56836ISI: 000396431100045OAI: oai:DiVA.org:oru-56836DiVA, id: diva2:1085143
Note

Funding Agency:

IBD-Character (a European Union 7th Framework Programme project)

Available from: 2017-03-28 Created: 2017-03-28 Last updated: 2018-09-16Bibliographically approved

Open Access in DiVA

No full text in DiVA

Search in DiVA

By author/editor
Halfvarson, Jonas
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
The Lancet
General Practice

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 172 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf